Inside Nephrology: A Weekly Review
Nefrologia
Advances in Nephrology: From PD Infections to Ciliopathies
This week we explore the latest in nephrology research, from updated guidelines for pediatric PD infections to advances in treating ciliopathies, lupus nephritis, and renal-cell carcinoma. We also discuss promising new antibiotics for UTIs and innovations in CKD management.
Bibliography
1. Clinical practice guideline for the prevention and management of peritoneal dialysis associated infections in children: 2024 update.
Authors: Warady BA, Same R, Borzych-Duzalka D, et al.
Journal: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2024 Sep
PMID: 39313225
DOI: 10.1177/08968608241274096
2. Ciliopathies and the Kidney: A Review.
Authors: McConnachie DJ, Stow JL, Mallett AJ
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation, 2021 Mar
PMID: 33039432
DOI: 10.1053/j.ajkd.2020.08.012
3. RAASi, MRA and FGF-23 in CKD progression: the usual suspects?
Authors: Cianciolo G, Provenzano M, Hu L, et al.
Journal: Minerva urology and nephrology, 2026 Apr
PMID: 40910758
DOI: 10.23736/S2724-6051.25.06082-3
4. B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial.
Authors: Furie RA, Aroca G, Cascino MD, et al.
Journal: Annals of the rheumatic diseases, 2022 Jan
PMID: 34615636
DOI: 10.1136/annrheumdis-2021-220920
5. Effect of Cefepime/Enmetazobactam vs Piperacillin/Tazobactam on Clinical Cure and Microbiological Eradication in Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis: A Randomized Clinical Trial.
Authors: Kaye KS, Belley A, Barth P, et al.
Journal: JAMA, 2022 Oct 4
PMID: 36194218
DOI: 10.1001/jama.2022.17034
6. Ciliopathies and the Kidney: A Review.
Authors: McConnachie DJ, Stow JL, Mallett AJ
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation, 2021 Mar
PMID: 33039432
DOI: 10.1053/j.ajkd.2020.08.012
7. Long-Term Immunosuppression Management: Opportunities and Uncertainties.
Authors: Wojciechowski D, Wiseman A
Journal: Clinical journal of the American Society of Nephrology : CJASN, 2021 Aug
PMID: 33853841
DOI: 10.2215/CJN.15040920
8. Robotic Surgery Techniques to Improve Traditional Laparoscopy.
Authors: Williamson T, Song SE
Journal: JSLS : Journal of the Society of Laparoendoscopic Surgeons, 2022 Apr-Jun
PMID: 35655469
DOI: 10.4293/JSLS.2022.00002
9. Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
Authors: Choueiri TK, Tomczak P, Park SH, et al.
Journal: The New England journal of medicine, 2021 Aug 19
PMID: 34407342
DOI: 10.1056/NEJMoa2106391
10. Post renal-transplant malignancy surveillance.
Authors: Manickavasagar R, Thuraisingham R
Journal: Clinical medicine (London, England), 2020 Mar
PMID: 32188647
DOI: 10.7861/clinmed.2019-0423
Authors: Warady BA, Same R, Borzych-Duzalka D, et al.
Journal: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2024 Sep
PMID: 39313225
DOI: 10.1177/08968608241274096
2. Ciliopathies and the Kidney: A Review.
Authors: McConnachie DJ, Stow JL, Mallett AJ
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation, 2021 Mar
PMID: 33039432
DOI: 10.1053/j.ajkd.2020.08.012
3. RAASi, MRA and FGF-23 in CKD progression: the usual suspects?
Authors: Cianciolo G, Provenzano M, Hu L, et al.
Journal: Minerva urology and nephrology, 2026 Apr
PMID: 40910758
DOI: 10.23736/S2724-6051.25.06082-3
4. B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial.
Authors: Furie RA, Aroca G, Cascino MD, et al.
Journal: Annals of the rheumatic diseases, 2022 Jan
PMID: 34615636
DOI: 10.1136/annrheumdis-2021-220920
5. Effect of Cefepime/Enmetazobactam vs Piperacillin/Tazobactam on Clinical Cure and Microbiological Eradication in Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis: A Randomized Clinical Trial.
Authors: Kaye KS, Belley A, Barth P, et al.
Journal: JAMA, 2022 Oct 4
PMID: 36194218
DOI: 10.1001/jama.2022.17034
6. Ciliopathies and the Kidney: A Review.
Authors: McConnachie DJ, Stow JL, Mallett AJ
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation, 2021 Mar
PMID: 33039432
DOI: 10.1053/j.ajkd.2020.08.012
7. Long-Term Immunosuppression Management: Opportunities and Uncertainties.
Authors: Wojciechowski D, Wiseman A
Journal: Clinical journal of the American Society of Nephrology : CJASN, 2021 Aug
PMID: 33853841
DOI: 10.2215/CJN.15040920
8. Robotic Surgery Techniques to Improve Traditional Laparoscopy.
Authors: Williamson T, Song SE
Journal: JSLS : Journal of the Society of Laparoendoscopic Surgeons, 2022 Apr-Jun
PMID: 35655469
DOI: 10.4293/JSLS.2022.00002
9. Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
Authors: Choueiri TK, Tomczak P, Park SH, et al.
Journal: The New England journal of medicine, 2021 Aug 19
PMID: 34407342
DOI: 10.1056/NEJMoa2106391
10. Post renal-transplant malignancy surveillance.
Authors: Manickavasagar R, Thuraisingham R
Journal: Clinical medicine (London, England), 2020 Mar
PMID: 32188647
DOI: 10.7861/clinmed.2019-0423
